| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.465 | 26.653 | 24.813 | 40.011 | 52.184 | 35.116 | 45.138 | 73.707 | 83.249 | 99.696 |
| Total Income - EUR | 24.169 | 38.657 | 35.835 | 40.016 | 52.187 | 35.244 | 45.182 | 76.498 | 84.623 | 100.497 |
| Total Expenses - EUR | 36.049 | 28.689 | 30.627 | 38.515 | 45.345 | 37.569 | 36.299 | 43.644 | 65.646 | 85.639 |
| Gross Profit/Loss - EUR | -11.880 | 9.968 | 5.208 | 1.500 | 6.842 | -2.325 | 8.884 | 32.854 | 18.977 | 14.858 |
| Net Profit/Loss - EUR | -11.880 | 9.435 | 4.849 | 1.100 | 6.320 | -2.660 | 8.441 | 32.181 | 18.257 | 12.752 |
| Employees | 0 | 1 | 2 | 3 | 3 | 1 | 1 | 2 | 3 | 3 |
Check the financial reports for the company - A&M Diagnostic Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 37.668 | 33.610 | 29.429 | 26.298 | 59.528 | 48.178 | 37.167 | 27.937 | 66.005 | 116.621 |
| Current Assets | 35.398 | 41.039 | 32.404 | 31.695 | 38.162 | 29.572 | 33.658 | 61.317 | 49.931 | 72.073 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 26.899 | 30.553 | 29.367 | 25.352 | 26.133 | 24.634 | 25.907 | 29.273 | 29.382 | 30.838 |
| Cash | 8.499 | 10.486 | 3.036 | 6.343 | 12.029 | 4.938 | 7.751 | 32.044 | 20.549 | 41.236 |
| Shareholders Funds | 54 | 9.479 | 14.177 | 15.017 | 21.046 | 17.987 | 8.489 | 40.697 | 58.831 | 71.256 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 73.012 | 65.169 | 47.656 | 42.977 | 76.644 | 59.762 | 62.336 | 48.558 | 57.106 | 117.438 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4931 - 4931" | |||||||||
| CAEN Financial Year |
4939
|
|||||||||
Comments - A&M Diagnostic Line Srl